AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2024
Mar 22, 2024
30320_dirs_2024-03-22_44289d1a-f8f8-4630-b790-9c50786581bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2024-03-21
Reporting Person: MAHON PAUL A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-21 | Common Stock | M | 6000 | $117.76 | Acquired | 42710 | Direct |
| 2024-03-21 | Common Stock | S | 857 | $234.1121 | Disposed | 41853 | Direct |
| 2024-03-21 | Common Stock | S | 238 | $235.7318 | Disposed | 41615 | Direct |
| 2024-03-21 | Common Stock | S | 3505 | $236.7143 | Disposed | 38110 | Direct |
| 2024-03-21 | Common Stock | S | 1400 | $237.3601 | Disposed | 36710 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-21 | Stock Options | $117.76 | M | 6000 | Disposed | 2027-03-15 | Common Stock (6000) | Direct |
Footnotes
F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2: Includes 118 shares acquired on March 4, 2024, under the United Therapeutics Corporation Employee Stock Purchase Plan.
F3: This transaction was executed in multiple trades at prices ranging from $233.74 to $234.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $235.16 to $236.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $236.20 to $237.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $237.22 to $237.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.